Prodrug compounds of edaravone and their medical use for treating or alleviating neurodegenerative or motor neuron diseases
KR20200010853A
Pharmaceutical composition for prevention or treatment of non-alcoholic steatohepatitis
KR20190064112A
Methods for preparing 4―phenylquinazolin―2(1H)―one using ionic liquid
KR20180107808A
Method for preparing extrapure fluorosulfonylimide with removing methallic cation
KR20180069277A
3-Component cocrystal
WO2017105090A1
Crystalline polymorph of l-carnitine orotate, production method therefor, or use thereof
KR20170071431A
Crystalline Polymorph of L-Carnitine orotate, Method for Preparing or Use Thereof
KR20180054955A
The Solid Active Pharmaceutical Ingredients Comprising Glyceryl phosphoryl choline for Improving the Stability of Hygroscopic Drug Substance, Use or Method for Preparing Thereof
KR20180026612A
Solid complex comprising curcumin and L-carnitine and oral compositions comprising the same
KR20170143141A
Crystalline Polymorphs of Varenicline Free Base, Method for Preparing or Use Thereof
KR20170136663A
Method for Separating of Sucrose by Selective Crystallization
KR20170055610A
Novel Fenofibric Acid Prodrugs with Improved Bioavailability
KR20170038990A
Methods for Manufacturing Cocrystal of Choline alfoscerate and Curcumin
KR20160109041A
Process for Production of Optically Active Indoline Derivatives or Salts Thereof
KR20160087959A
Carbazole Derivatives and Organic light emitting device Comprising the Same
KR101501253B1
Crystalline Febuxostat Pidolate Salt and Method for Preparing Thereof
